Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress
- 15 March 2002
- journal article
- perspective
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (8) , 1543-1558
- https://doi.org/10.1021/jm010468s
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- UCS15A, a non-kinase inhibitor of Src signal transductionOncogene, 2001
- A ligand-reversible dimerization system for controlling protein–protein interactionsProceedings of the National Academy of Sciences, 2000
- Regulation of Protein Secretion Through Controlled Aggregation in the Endoplasmic ReticulumScience, 2000
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Structure-Based Design, Synthesis, and X-ray Crystallography of a High-Affinity Antagonist of the Grb2-SH2 Domain Containing an Asparagine MimeticJournal of Medicinal Chemistry, 1999
- Potent Antagonists of the SH2 Domain of Grb2: Optimization of the X+1 Position of 3-Amino-Z-Tyr(PO3H2)-X+1-Asn-NH2Journal of Medicinal Chemistry, 1998
- Structure-Based Design of a Novel Series of Nonpeptide Ligands That Bind to the pp60src SH2 DomainJournal of the American Chemical Society, 1997
- On the origins of the DNA sequence selectivity of mitomycin monoalkylation transformationsJournal of the American Chemical Society, 1992
- A novel genetic system to detect protein–protein interactionsNature, 1989
- Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion.The Journal of cell biology, 1983